Creon pancrelipase regulatory update

FDA approved an sNDA for Creon pancrelipase delayed-release capsules from Abbott to treat exocrine pancreatic insufficiency due to cystic fibrosis (CF), chronic pancreatitis, pancreatectomy or other c...